Found: 24
Select item for more details and to access through your institution.
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.955894
- By:
- Publication type:
- Article
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 223, doi. 10.3390/cancers11020223
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
- Published in:
- Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/11795549211021667
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
- Published in:
- Clinical Medicine Insights: Oncology, 2021, v. 15, p. 1, doi. 10.1177/11795549211021667
- By:
- Publication type:
- Article
Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy Among Patients With Adverse Pathology at Radical Prostatectomy.
- Published in:
- AUANews, 2022, v. 27, p. 12
- By:
- Publication type:
- Article
Adjuvant immunotherapy in patients with high‐risk muscle‐invasive urothelial carcinoma: The potential impact of informative censoring.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 15, p. 2892, doi. 10.1002/cncr.34255
- By:
- Publication type:
- Article
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
- Published in:
- Journal of Endourology, 2016, v. 30, n. 10, p. 1112, doi. 10.1089/end.2016.0458
- By:
- Publication type:
- Article
Association of an aurora kinase a ( AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 4, p. 524, doi. 10.1007/s10637-017-0440-5
- By:
- Publication type:
- Article
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 2, p. 236, doi. 10.1007/s10637-016-0328-9
- By:
- Publication type:
- Article
Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37568-9
- By:
- Publication type:
- Article
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma.
- Published in:
- Therapeutic Advances in Urology, 2015, v. 7, n. 3, p. 152, doi. 10.1177/1756287215574457
- By:
- Publication type:
- Article
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node‐positive penile squamous cell carcinoma.
- Published in:
- BJU International, 2020, v. 125, n. 6, p. 867, doi. 10.1111/bju.15054
- By:
- Publication type:
- Article
Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection.
- Published in:
- BJU International, 2020, v. 125, n. 1, p. 82, doi. 10.1111/bju.14883
- By:
- Publication type:
- Article
First‐line therapy with dacomitinib, an orally available pan‐HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open‐label, single‐arm, single‐centre, phase 2 study
- Published in:
- BJU International, 2018, v. 121, n. 3, p. 348, doi. 10.1111/bju.14013
- By:
- Publication type:
- Article
Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases.
- Published in:
- BJU International, 2015, v. 116, n. 5, p. 727, doi. 10.1111/bju.12510
- By:
- Publication type:
- Article
Pulmonary lesion after surgery for renal cancer: progression or new primary?
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05041-x
- By:
- Publication type:
- Article
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-04976-5
- By:
- Publication type:
- Article
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 6, p. 1573, doi. 10.1007/s00345-023-04413-z
- By:
- Publication type:
- Article
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?
- Published in:
- World Journal of Urology, 2022, v. 40, n. 11, p. 2667, doi. 10.1007/s00345-022-04153-6
- By:
- Publication type:
- Article
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
- Published in:
- World Journal of Urology, 2021, v. 39, n. 9, p. 3407, doi. 10.1007/s00345-021-03635-3
- By:
- Publication type:
- Article
Vesical Imaging‐Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle‐invasive bladder cancer.
- Published in:
- BJU International, 2024, v. 133, n. 2, p. 214, doi. 10.1111/bju.16191
- By:
- Publication type:
- Article
The immune‐related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials.
- Published in:
- BJU International, 2024, v. 133, n. 2, p. 158, doi. 10.1111/bju.16121
- By:
- Publication type:
- Article
Renal function outcomes in patients with muscle‐invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE‐01 study.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 186, doi. 10.1002/ijc.33554
- By:
- Publication type:
- Article